BamSEC and AlphaSense Join Forces
Learn More

Sophiris Bio Inc.

Formerly NASDAQ: SPHS
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 26 pages Development Agreement by and Between Sophiris Bio Corp. and Vetter Pharma International Gmbh — II —
12/34/56
EX-10.1
from 8-K 45 pages Sophiris Bio Inc. Common Shares (No Par Value) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.2
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 19 pages Placement Agency Agreement
12/34/56
EX-10
from 10-Q 7 pages Officer Change in Control Severance Benefit Agreement
12/34/56
EX-10
from 10-Q 7 pages Officer Change in Control Severance Benefit Agreement
12/34/56
EX-10
from 10-Q 9 pages Officer Change in Control Severance Benefit Agreement
12/34/56
EX-10.1
from 8-K ~20 pages Common Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K ~5 pages Sophiris Bio Inc. Omnibus Amendment to Warrants to Purchase Common Shares
12/34/56
EX-10.1
from 8-K 6 pages Sophiris Bio Inc. Omnibus Amendment to Common Shares Purchase Warrants
12/34/56
EX-10.26
from S-1/A 24 pages Agreement Respecting Intellectual Property
12/34/56
EX-10.24
from S-1 1 page Sophiris Bio Inc. 2012 Non-Employee Director Compensation Program
12/34/56
EX-10.23
from S-1 88 pages Technology Transfer and Supply Agreement Between: Sophiris Bio Corp. (Formerly Protox Therapeutics Corp.) 1258 Prospect Street, La Jolla California USA (Hereinafter Referred to as “Sophiris”) and Boehringer Ingelheim Rcv Gmbh & Co Kg Dr. Boehringer Gasse 5-11 A-1121 Vienna, Austria
12/34/56
EX-10.22
from S-1 4 pages Protox Therapeutics Inc. 1210-885 West Georgia Street Vancouver, Bc Canada V6c
12/34/56
EX-10.21
from S-1 5 pages Intellectual Property Security Agreement
12/34/56
EX-10.20
from S-1 7 pages Intellectual Property Security Agreement
12/34/56
EX-10.18
from S-1 1 page First Amendment to That Certain Lease Agreement Dated April 15, 2011, by and Between Allison-Zongker, L.P. (“Landlord”), and Protox Therapeutics Corp., a Delaware Corporation (“Tenant”). 1. Effective April 2, 2012, Tenant Officially Changed Its Corporate Name to Sophiris Bio, Corp. All Rights, Duties and Obligations of Protox Therapeutics Corp. Remain Unchanged Under the New Corporate Name. 2. Expansion of Premises. Effective September 1, 2012, the Leased Premises Are Expanded to Include the 1,061 Square Feet Known as 1258 1/2 Prospect Street, Which Is Located One Floor Below the Existing Offices of Tenant
12/34/56
EX-10.17
from S-1 32 pages Standard Lease*
12/34/56
EX-10.16
from S-1 6 pages Office Service Agreement
12/34/56